Center for drug evaluation and research (CDER), office of communications (OCOMM) - generic drugs and biosimilars: education and outreach initiative
Ended Awarded Last action
- Contract number
- HHSF223201610481G
- Awardee
-
Palladian Partners, Inc. UEI SJGQXJEFBKC5 Part of Altarum Institute
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $2,157,054
Award facts
- Opportunity
-
- 7FCBH2070541B Solicitation number
- Contract value 100% obligated
- $2,157,054.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541820 Public Relations Agencies
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Time and Materials
- Place of performance
- Rockville, MD 20857, USA
- Legislative mandates
-
- Economy Act FAR subpart 17.5
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$60,174 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Additional Work (new agreement, FAR part 6 applies) | $647,686 | |
| Change Order | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $857,031 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $712,512 |
About this award
This is a delivery order awarded by the Food and Drug Administration (FDA) to Palladian Partners, Inc., a for-profit communications firm and subsidiary of the Altarum Institute, a nonprofit research and consulting organization. The $2,157,054.32 contract is for the Center for Drug Evaluation and Research (CDER), Office of Communications (OCOMM) to provide an "Education and Outreach Initiative" related to generic drugs and biosimilars. The contract was awarded under the General Services Administration's (GSA) Professional Services Schedule (PSS) on a time and materials basis, with no set-aside designation. Palladian Partners has received numerous other federal contract awards, including a $37.3 million contract for communications support of the National Institutes of Health's (NIH) All of Us Research Program and a $19.4 million contract for the National Institute of Child Health and Human Development. The company also holds several federal Indefinite Delivery Vehicles, including a $261.4 million Multiple Award Schedule contract with GSA and Blanket Purchase Agreements with NIH and the Substance Abuse and Mental Health Services Administration.
Quick answers
Who was awarded contract HHSF223201610481G?
HHSF223201610481G was awarded to Palladian Partners, Inc. by Food and Drug Administration (Department of Health and Human Services) on September 29, 2016.
How much is contract HHSF223201610481G worth?
The government has obligated $2,157,054 on HHSF223201610481G.
Is contract HHSF223201610481G an order under another contract?
Yes. HHSF223201610481G is a delivery order under GS23F0270L, a federal supply schedule, on The Professional Services Schedule (PSS).
Was contract HHSF223201610481G competed?
The extent of competition for HHSF223201610481G was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award